Randomized, double-blind, multicenter trial comparing two doses of Arzoxifene (LY353381) in hormone-sensitive advanceor metastitic breast cancer patients | Charles Explorer

Randomized, double-blind, multicenter trial comparing two doses of Arzoxifene (LY353381) in hormone-sensitive advanceor metastitic breast cancer patients

Publikace na 1. lékařská fakulta |

2003

Abstrakt

Arzoxifene, breast cancer, study

Osoby